Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption
Targeting ligands on drug carriers can trigger immune responses. Here, the authors modify liposomes with a peptidomimetic that preserves bioactivity of the nanocarrier in blood circulation and attenuates IgM absorption, thereby improving the immunocompatibility of brain-targeted liposomes.
Guardado en:
Autores principales: | Juan Guan, Qing Shen, Zui Zhang, Zhuxuan Jiang, Yang Yang, Meiqing Lou, Jun Qian, Weiyue Lu, Changyou Zhan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de6780060c3d401faf616e76a93f9070 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Brain-targeted drug delivery by manipulating protein corona functions
por: Zui Zhang, et al.
Publicado: (2019) -
IgD attenuates the IgM-induced anergy response in transitional and mature B cells
por: Zahra Sabouri, et al.
Publicado: (2016) -
Serum IgM Glycosylation Associated with Tuberculosis Infection in Mice
por: Tadahiro Kumagai, et al.
Publicado: (2019) -
Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response
por: Kristina Borochova, et al.
Publicado: (2021) -
SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses
por: He-wei Jiang, et al.
Publicado: (2020)